StockNews.AI
IQV
StockNews.AI
105 days

IQVIA Reports First-Quarter 2025 Results

1. IQV's Q1 2025 revenue rose to $3,829 million, a 2.5% increase. 2. Strong performance indicates growth in clinical research and healthcare intelligence sectors.

Earnings
-0.24%Current Return
VS
-1.04%S&P 500
$152.305/06 07:08 AM EDTEvent Start
$151.9305/07 02:07 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

IQV's consistent revenue growth is indicative of robust demand for its services, similar to past earnings reports that led to price increases. The positive growth in a competitive landscape enhances investor sentiment.

How important is it?

Strong earnings results can significantly sway investor perception and decisions regarding IQV, making this information highly weighted for future stock evaluations.

Why Short Term?

The immediate impact of quarterly results typically influences stock prices within a few weeks, as seen in prior earnings releases where price adjustments occurred quickly.

Related Companies

PRGOIQVBAX
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended March 31, 2025. First-Quarter 2025 Operating Results Revenue for the first quarter of $3,829 million increased 2.5 percent on a reported basis and 3.5 percent at constant currency, compared to the first.

Related News